PURPLE BIOTECH LTD. - Ordinary Shares, no par value per share (PPBT) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2024 to Q4 2025

Type / Class
Equity / Ordinary Shares, no par value per share
Symbol
PPBT on Nasdaq
Shares outstanding
1,806,796,154
Price per share
$0.61
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
780,508
Total reported value
$513,183
% of total 13F portfolios
0%
Share change
+590,763
Value change
+$392,637
Number of holders
17
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of PURPLE BIOTECH LTD. - Ordinary Shares, no par value per share (PPBT) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
INTRACOASTAL CAPITAL, LLC 10% 0% $113,957,926 +$34,576,864 200,453,695 +44% Mitchell P. Kopin 30 Sep 2025
SUSQUEHANNA SECURITIES, LLC 5.2% $63,888,312 93,953,400 Susquehanna Securities, LLC 31 Dec 2025
Lincoln Alternative Strategies LLC 9.9% $1,288,650 605,000 Lincoln Alternative Strategies LLC 04 Sep 2025
Orca Capital AG 4.9% $652,619 306,394 Orca Capital AG 04 Sep 2025

As of 31 Dec 2025, 17 institutional investors reported holding 780,508 shares of PURPLE BIOTECH LTD. - Ordinary Shares, no par value per share (PPBT). This represents 0.04% of the company’s total 1,806,796,154 outstanding shares.

Institutional Holders of PURPLE BIOTECH LTD. - Ordinary Shares, no par value per share (PPBT) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 780,508 $513,183 +$392,637 $0.66 17
2025 Q3 132,491 $75,781 +$9,482 $0.57 11
2025 Q2 56,968 $133,604 +$12,851 $2.34 10
2025 Q1 50,573 $134,236 -$128,880 $2.66 7
2024 Q4 80,346 $376,821 -$567,897 $4.69 12
2024 Q3 170,369 $945,992 +$925,596 $5.56 9